Free Trial
CVE:KNE

Kane Biotech (KNE) Stock Price, News & Analysis

Kane Biotech logo
C$0.04 +0.00 (+7.50%)
As of 09:36 AM Eastern

About Kane Biotech Stock (CVE:KNE)

Key Stats

Today's Range
C$0.04
C$0.04
50-Day Range
C$0.04
C$0.06
52-Week Range
C$0.04
C$0.16
Volume
1,000 shs
Average Volume
77,141 shs
Market Capitalization
C$6.19 million
P/E Ratio
1.08
Dividend Yield
3.08%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive KNE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kane Biotech and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KNE Stock News Headlines

BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.tc pixel
Kane Biotech to Present at Advanced Wound Care Summit USA
Kane Biotech to Present at Advanced Wound Care Summit USA
Kane Biotech Provides Further Corporate Update
See More Headlines

KNE Stock Analysis - Frequently Asked Questions

Kane Biotech's stock was trading at C$0.11 at the beginning of 2025. Since then, KNE shares have decreased by 61.8% and is now trading at C$0.04.

Shares of KNE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kane Biotech investors own include Mason Resources (LLG), Datametrex AI (DM) and Allstar Health Brands (ALST).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:KNE
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$0.04
Trailing P/E Ratio
1.05
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$6.03 million
Net Margins
423.52%
Pretax Margin
N/A
Return on Equity
-94.49%
Return on Assets
-58.43%

Debt

Debt-to-Equity Ratio
-331.42
Current Ratio
0.80
Quick Ratio
0.39

Sales & Book Value

Annual Sales
C$1.42 million
Price / Sales
4.25
Cash Flow
C$0.00 per share
Price / Cash Flow
8.50
Book Value
C($0.01) per share
Price / Book
-8.16

Miscellaneous

Outstanding Shares
144,060,190
Free Float
N/A
Market Cap
C$6.05 million
Optionable
Not Optionable
Beta
0.52
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (CVE:KNE) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners